GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.51 $159.34 Friday, 19th Apr 2024 ALNY stock ended at $144.41. This is 0.517% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 2.38% from a day low at $143.51 to a day high of $146.92.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2021-03-22 $143.57 $146.87 $140.70 $144.15 574 777
2021-03-19 $141.43 $144.62 $138.88 $144.16 983 185
2021-03-18 $143.15 $144.86 $139.79 $140.04 341 546
2021-03-17 $142.34 $146.61 $141.51 $145.15 456 942
2021-03-16 $147.34 $148.54 $142.07 $143.78 632 806
2021-03-15 $142.00 $146.25 $141.15 $146.12 535 145
2021-03-12 $140.69 $142.49 $137.07 $142.20 465 850
2021-03-11 $138.21 $143.70 $136.49 $142.98 701 966
2021-03-10 $139.63 $139.85 $134.12 $134.68 496 464
2021-03-09 $141.88 $143.41 $137.60 $137.68 870 971
2021-03-08 $142.14 $144.50 $138.29 $138.62 580 485
2021-03-05 $136.95 $143.42 $133.09 $143.39 486 876
2021-03-04 $143.35 $144.72 $136.89 $137.37 790 218
2021-03-03 $151.91 $152.00 $143.54 $144.32 499 699
2021-03-02 $149.29 $153.25 $148.07 $152.41 569 586
2021-03-01 $149.36 $151.35 $147.95 $148.75 442 922
2021-02-26 $147.01 $149.00 $143.91 $148.10 500 633
2021-02-25 $151.92 $154.80 $143.43 $146.59 461 453
2021-02-24 $152.75 $155.57 $150.83 $151.59 363 263
2021-02-23 $147.00 $154.31 $143.34 $153.21 593 635
2021-02-22 $150.91 $153.61 $148.00 $148.07 469 508
2021-02-19 $152.14 $155.53 $151.33 $155.06 679 660
2021-02-18 $154.60 $156.44 $150.17 $150.23 711 646
2021-02-17 $152.44 $157.00 $150.07 $156.53 512 412
2021-02-16 $160.92 $160.92 $150.51 $153.81 803 036
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT